INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $296,000 | +127.7% | 91,500 | -5.3% | 0.40% | +81.4% |
| Q4 2016 | $130,000 | +712.5% | 96,600 | +856.4% | 0.22% | +94.7% |
| Q3 2016 | $16,000 | -99.0% | 10,100 | -94.7% | 0.11% | -19.9% |
| Q3 2015 | $1,607,000 | +28.1% | 190,200 | +66.1% | 0.14% | +34.3% |
| Q2 2015 | $1,254,000 | -6.8% | 114,500 | +18.9% | 0.10% | -7.9% |
| Q1 2015 | $1,346,000 | -18.2% | 96,300 | -1.1% | 0.11% | -19.7% |
| Q4 2014 | $1,645,000 | +98.7% | 97,400 | +57.9% | 0.14% | +91.9% |
| Q3 2014 | $828,000 | +331.2% | 61,700 | +308.6% | 0.07% | +362.5% |
| Q2 2014 | $192,000 | – | 15,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |